Dermatology

Primary care physicians are pivotal in the early recognition and referral of rare eosinophilic diseases, such as hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA), which remain underdiagnosed despite their serious multisystem impact.

A nationwide study of basal cell carcinoma (BCC) excisions in Denmark found that hospital-based specialists have significantly lower odds of incomplete removal than their practice-based peers, raising important questions about treatment setting and provider expertise.

Patients with autoimmune skin diseases (ASDs) may have improved survival following cancer treatment, according to a large population-based study, suggesting a possible immunologic advantage in oncologic outcomes.

A new perspective on atopic dermatitis suggests that disruptions to the skin’s microbial ecosystem and routine bathing practices may play a larger role in the disease’s origin and progression than previously recognized.

Emerging immunotherapies are transforming the treatment landscape for pemphigus and bullous pemphigoid, two distinct autoimmune blistering skin diseases marked by pathogenic autoantibodies and significant patient burden.

In a compelling case that underscores the complexity of biologic therapies, a patient with hidradenitis suppurativa (HS) developed adalimumab-induced pustular psoriasis, which was successfully treated with guselkumab.

Acne has emerged as a frequent and clinically relevant side effect in patients with inflammatory bowel disease (IBD) treated with JAK inhibitors, according to the largest international retrospective cohort study to date on this adverse event.

A growing number of anaphylaxis cases linked to cashew nuts, especially in children, combined with an unexpected frequency of almond-induced reactions in adults, signals a shift in the landscape of tree nut allergies, according to new data from the European Anaphylaxis Registry.